Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Genesis Lifestyle Medicine vs MEDVidi

Genesis Lifestyle Medicine
Graded #392

Lower grade

vs+0.29999999999999716
MEDVidi
Graded #384

Higher grade

The verdict

MEDVidi takes it — 58/100 to 57.7/100, but only just.

MEDVidi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MEDVidi is a US telehealth platform whose licensed providers evaluate patients and prescribe GLP-1 weight-management medications, including brand-name Zepbound (tirzepatide) and Wegovy (semaglutide), plus… Genesis Lifestyle Medicine is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEven
53
53
Clinical oversightGenesis Lifestyle Medicine +1
78
77
Labs & monitoringMEDVidi +10
52
62
FulfillmentGenesis Lifestyle Medicine +8
67
59
Contract termsEven
55
55
Genesis Lifestyle Medicine · left barMEDVidi · right bar

The numbers

MetricGenesis Lifestyle MedicineMEDVidi
WeighScore57.7/10058/100
GradeCC
Scorecard rank#392#384
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
Coverage8 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only

Strengths

  • 18 physical clinics allow in-person consults and injections across 8 states
  • Dual modality — compounded sema/tirz plus brand-name Wegovy and Zepbound on one platform
  • Med spa model lets patients combine weight loss, hormone therapy, and aesthetics
  • Established brand with an 18-location footprint and patient testimonials
  • Telehealth available for remote patients in served states

Where it loses points

  • Pricing not disclosed publicly — gated behind the consultation flow
  • Specific 503A/503B pharmacy partner not named, and the designation not specified
  • No FDA compounded-medication disclaimer visible on the homepage
  • Named medical director not formally disclosed (only a 'Dr. Spinoso' testimonial)
  • Corporate legal entity and governing law not disclosed
MEDVidi

Graded #384 · C

Strengths

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

Where it loses points

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard